Eva Løbner Lund

1.2k total citations
45 papers, 753 citations indexed

About

Eva Løbner Lund is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Eva Løbner Lund has authored 45 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Neurology. Recurrent topics in Eva Løbner Lund's work include Cancer, Hypoxia, and Metabolism (12 papers), Angiogenesis and VEGF in Cancer (9 papers) and Prion Diseases and Protein Misfolding (8 papers). Eva Løbner Lund is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Angiogenesis and VEGF in Cancer (9 papers) and Prion Diseases and Protein Misfolding (8 papers). Eva Løbner Lund collaborates with scholars based in Denmark, United Kingdom and Italy. Eva Løbner Lund's co-authors include Paul E.G. Kristjansen, Lone Bastholm, Lasse Tengbjerg Hansen, Nanna Junker, Julia S. Johansen, Carsten Dan Ley, Søren Holm, Liselotte Højgaard, Svend A. Engelholm and Mogens Spang‐Thomsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Eva Løbner Lund

41 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Løbner Lund Denmark 15 408 235 212 91 86 45 753
Shanbao Cai United States 18 548 1.3× 153 0.7× 328 1.5× 106 1.2× 69 0.8× 35 864
Jason Whitt United States 11 478 1.2× 160 0.7× 268 1.3× 49 0.5× 82 1.0× 26 807
Aswin Abraham Canada 11 376 0.9× 205 0.9× 136 0.6× 98 1.1× 61 0.7× 30 718
Sonali P. Barwe United States 20 714 1.8× 206 0.9× 97 0.5× 111 1.2× 51 0.6× 66 1.1k
Kai Doberstein Germany 19 524 1.3× 299 1.3× 249 1.2× 116 1.3× 36 0.4× 27 1.1k
Junhye Kwon South Korea 18 594 1.5× 274 1.2× 205 1.0× 93 1.0× 26 0.3× 31 854
Zibin Jiang United States 11 577 1.4× 287 1.2× 358 1.7× 140 1.5× 96 1.1× 18 937
Ján Remšík United States 14 441 1.1× 356 1.5× 269 1.3× 223 2.5× 81 0.9× 33 977
Evelyn Aranda United States 11 412 1.0× 210 0.9× 126 0.6× 55 0.6× 29 0.3× 12 753

Countries citing papers authored by Eva Løbner Lund

Since Specialization
Citations

This map shows the geographic impact of Eva Løbner Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Løbner Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Løbner Lund more than expected).

Fields of papers citing papers by Eva Løbner Lund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Løbner Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Løbner Lund. The network helps show where Eva Løbner Lund may publish in the future.

Co-authorship network of co-authors of Eva Løbner Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Løbner Lund. A scholar is included among the top collaborators of Eva Løbner Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Løbner Lund. Eva Løbner Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waldemar, Gunhild, Anja Hviid Simonsen, Marie Bruun, et al.. (2025). Prodromal Lewy Body Symptoms and α‐Synuclein Seeding in Idiopathic Olfactory Dysfunction. Movement Disorders Clinical Practice. 13(2). 494–502.
2.
Lund, Eva Løbner, et al.. (2025). Small fiber neuropathy following COVID-19 vaccination: A case series. Journal of the Neurological Sciences. 474. 123536–123536. 1 indexed citations
3.
Simonsen, Anja Hviid, Kristian Steen Frederiksen, Kirsten Svenstrup, et al.. (2025). Seeding amplification assay with Universal Control Fluid: Standardized detection of α-synucleinopathies. PLoS ONE. 20(6). e0326568–e0326568. 2 indexed citations
4.
Larsen, Karen Bonde, Pitt Niehusmann, Eva Løbner Lund, et al.. (2023). Postprocessing of MRIs Using FreeSurfer in Epilepsy Surgery Patients Provides an Excellent Imaging Marker of Hippocampal Sclerosis but Fails to Separate Subtypes. Acta Neurologica Scandinavica. 2023. 1–10. 1 indexed citations
5.
Lund, Eva Løbner, et al.. (2023). Improved Real-Time Quaking Induced Conversion for Early Diagnostics of Creutzfeldt–Jakob Disease in Denmark. International Journal of Molecular Sciences. 24(7). 6098–6098.
6.
Melchior, Linea Cecilie, Bojan Kovacevic, Pia Klausen, et al.. (2022). Targeted next-generation sequencing of EUS-guided through-the-needle-biopsy sampling from pancreatic cystic lesions. Gastrointestinal Endoscopy. 97(1). 50–58.e4. 19 indexed citations
8.
Lund, Eva Løbner, et al.. (2021). Undiagnosed acromegaly as an underlying cause of sudden death. Forensic Science Medicine and Pathology. 17(2). 322–326. 3 indexed citations
9.
Litman, Thomas, Helle Broholm, Linea Cecilie Melchior, et al.. (2020). Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt–Jakob Disease Patients. International Journal of Molecular Sciences. 22(1). 140–140. 7 indexed citations
10.
Broholm, Helle, Linea Cecilie Melchior, Anna Bartoletti‐Stella, et al.. (2019). Molecular Characterization of the Danish Prion Diseases Cohort With Special Emphasis on Rare and Unique Cases. Journal of Neuropathology & Experimental Neurology. 78(11). 980–992. 4 indexed citations
11.
Høgh, Peter, Anna Bartoletti‐Stella, Linea Cecilie Melchior, et al.. (2019). A Novel Eight Octapeptide Repeat Insertion in PRNP Causing Prion Disease in a Danish Family. Journal of Neuropathology & Experimental Neurology. 78(7). 595–604. 9 indexed citations
12.
Lund, Eva Løbner, et al.. (2009). Tumor angiogenesis - a new therapeutic target in gliomas. Acta Neurologica Scandinavica. 97(1). 52–62. 20 indexed citations
13.
Tazzyman, Simon, Eva Løbner Lund, Nanna Junker, et al.. (2008). Hypoxia-induced secretion of macrophage migration-inhibitory factor from MCF-7 breast cancer cells is regulated in a hypoxia-inducible factor-independent manner. Cancer Letters. 265(2). 239–249. 32 indexed citations
14.
Ley, Carsten Dan, et al.. (2006). Angiopoietin-4 Inhibits Angiogenesis and Reduces Interstitial Fluid Pressure. Neoplasia. 8(5). 364–372. 25 indexed citations
15.
Ley, Carsten Dan, et al.. (2004). Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay. Microvascular Research. 68(3). 161–168. 46 indexed citations
16.
Lund, Eva Løbner, et al.. (2004). Differential regulation of VEGF, HIF1α and angiopoietin‐1, ‐2 and ‐4 by hypoxia and ionizing radiation in human glioblastoma. International Journal of Cancer. 108(6). 833–838. 58 indexed citations
19.
Kragh, Michael, Bjørn Quistorff, Eva Løbner Lund, & Paul E.G. Kristjansen. (2001). Quantitative Estimates of Vascularity in Solid Tumors by Non-Invasive Near-Infrared Spectroscopy. Neoplasia. 3(4). 324–330. 17 indexed citations
20.
Lund, Eva Løbner, Lone Bastholm, & Paul E.G. Kristjansen. (2000). Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.. PubMed. 6(3). 971–8. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026